Skip to main content
SpringerLink
Log in

Pharmakotherapie bei prophylaxeresistenten affektiven Störungen

  • Chapter
Die Lithiumtherapie

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ahlfors UG, Baastrup PC, Dencker SJ, Elgen G, Lingjaerde M, Pedersen V, Schou M, Aaskoven O (1981) Flupenthixol decanoate in recurrent manic depressive illness: a comparison with lithium. Acta Psychiatr Scand 64: 226–237

    Article  PubMed  CAS  Google Scholar 

  • Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L (1995) Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 152: 1130–1138

    PubMed  CAS  Google Scholar 

  • American Psychiatric Association (1994a) Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 151 (Dec Suppl): 1–36

    Google Scholar 

  • American Psychiatric Association (1994b) Diagnostic and Statistical Manual: DSM-IV. 4th ed. American Psychiatric Press, Washington (DC )

    Google Scholar 

  • Aronson TA, Shukla S, Hirschowitz J (1989) Clonazepam treatment of five lithium-re-fractory patients with bipolar disorder. Am J Psychiatry 146: 77–80

    PubMed  CAS  Google Scholar 

  • Banov MD, Zarate CA, Tohen M, Scialabba D, Wines JD, Kolbrener M, Kim JW, Cole JO (1994) Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. J Clin Psychiatry 55: 295–300

    PubMed  CAS  Google Scholar 

  • Bauer M (1997) Adjuvante Schilddrusenhormonbehandlung bei therapieresistenten affektiven Störungen. In: Bauer M, Berghöfer A (Hrsg.) Therapieresistente Depressionen. Springer, Berlin Heidelberg New York, S. 138–151

    Google Scholar 

  • Bauer MS, Whybrow PC (1986) The effect of changing thyroid function on cyclic affective illness in a human subject. Am J Psychiatry 143: 633–636

    PubMed  CAS  Google Scholar 

  • Bauer MS, Whybrow PC (1990) Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study. Arch Gen Psychiatry 47: 435–440

    PubMed  CAS  Google Scholar 

  • Bauer MS, Whybrow PC, Winokur A (1990) Rapid cycling bipolar affective disorder. I. Association with grade I hypothyroidism. Arch Gen Psychiatry 47: 427–432

    PubMed  CAS  Google Scholar 

  • Whybrow PC (1991) Rapid cycling bipolar disorder: clinical features, treatment, and etiology. In: Amsterdam JD (ed) Advances in Neuropsychiatry and Psychopharmacology, vol. 2: Refractory depression. Raven Press, New York, pp. 191–208

    Google Scholar 

  • Bauer MS, Calabrese J, Dunner DL, Post R, Whybrow PC, Gyulai L, Tay LK, Younkin SR, Bynum D, Lavori P, Price RA (1994) Multisite data reanalysis of the validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV. Am J Psychiatry 151: 506–515

    PubMed  CAS  Google Scholar 

  • Bauer M, Ahrens B (1996) Bipolar disorder. A practical guide to drug treatment. CNS Drugs 6 (1): 35–52

    Article  CAS  Google Scholar 

  • Bauer M, Hellweg R, Baumgartner A (1996) Adjunctive treatment with high-dose thy-roxine in refractory depression (Abstract). American Psychiatric Association New Research Program and Abstracts 1996: 156

    Google Scholar 

  • Baumgartner A, Bauer M, Hellweg R (1994) Treatment of intractable non-rapid cycling bipolar affective disorder with high-dose thyroxine: an open clinical trial. Neuro-psychopharmacol 10: 183–189

    CAS  Google Scholar 

  • Bernstein L (1992) Abrupt cessation of rapid-cycling bipolar disorder with the addition of low-dose L-tetraiodothyronine to lithium. J Clin Psychopharmacol 12: 443–444

    Article  PubMed  CAS  Google Scholar 

  • Cabrera J, Albrecht J, Müller-Oerlinghausen B (1987) Kombinierte rezidiv-prophylaktische Behandlung der manisch-depressiven Erkrankung mit Lithium and Carbamazepin oder Oxcarbazepin. Nervenarzt 58: 245–249

    PubMed  CAS  Google Scholar 

  • Calabrese JR, Meltzer HY, Markovitz PJ (1991) Clozapine prophylaxis in rapid cycling bipolar disorder. J Clin Psychopharmacol 11: 396–397

    Article  PubMed  CAS  Google Scholar 

  • Calabrese JR, Markovitz PJ, Kimmel SE, Wagner SC (1992) Spectrum of efficacy of val-proate in 78 rapid-cycling bipolar patients. J Clin Psychopharmacol 12: 53–56

    Google Scholar 

  • Calabrese JR, Fatemi SH, Woyshville (1996) Antidepressant effects of lamotrigine in rapid cycling bipolar disorder. Am J Psychiatry 153: 1236

    Google Scholar 

  • Coryell W, Endicott J, Keller M (1992) Rapidly cycling affective disorder. Demographics, diagnosis, family history, and course. Arch Gen Psychiatry 49: 126–131

    PubMed  CAS  Google Scholar 

  • Di Costanzo E, Schifano F (1991) Lithium alone or in combination with carbamazepine for the treatment of rapid-cycling bipolar affective disorder. Acta Psychiatr Scand 83: 456–459

    Article  PubMed  Google Scholar 

  • Dubovsky SL, Buzan R (1995) The role of calcium channel blockers in the treatment of psychiatric disorders. CNS Drugs 4 (1): 47–57

    Article  Google Scholar 

  • Dunner DL, Fieve RR (1974) Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 30: 229–233

    PubMed  CAS  Google Scholar 

  • Emrich GN, Dose M, von Zerssen D (1985) The use of sodium valproate, carbamazepine and oxcarbamazepine in patients with affective disorders. J Aff Disord 8: 243–250

    Article  CAS  Google Scholar 

  • Esparon J, Kolloori J, Naylor GJ, McHarg AM, Smith AHW, Hopwood SE (1986) Comparison of the prophylactic action of flupenthixol with placebo in lithium-treated manic-depressive patients. Br J Psychiatry 148: 723–725

    Article  PubMed  CAS  Google Scholar 

  • Fawcett J, Kravitz HM (1985) The long-term management of bipolar disorders with lithium, carbamazepine, and antidepressants. J Clin Psychiatry 46:58-60 Frankenburg FR (1993) Clozapine and bipolar disorder. J Clin Psychopharmacol 13: 289–299

    Google Scholar 

  • Fritze J, Beneke M, Lanczik M, Schneider B, Walden J (1994) Carbamazepine as adjunct or alternative to lithium in the prophylaxis of recurrent affective disorders. Pharmacopsychiatry 27: 181–185

    Article  PubMed  CAS  Google Scholar 

  • Frye MA (1996) The increasing use of polypharmacy for refractory mood disorders: twenty-five years of study (abstract). American Psychiatric Association New Re-search Program and Abstracts 1996: 151–152

    Google Scholar 

  • Gelenberg AJ, Kane JM, Keller MB, Lavori P, Rosenbaum JF, Cole K, Lavelle J (1986) Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorders. N Engl J Med 321: 1489–1493

    Article  Google Scholar 

  • Goodnick PJ (1995) Nimodipine treatment of rapid cycling bipolar disorder. J Clin Psychiatry 56: 330

    PubMed  CAS  Google Scholar 

  • Goodwin FK, Jamison KR (1990) Manic-depressive illness. Oxford University Press, New York

    Google Scholar 

  • Gyulai L, Jaggi J, Bauer MS, Younkin S, Rubin L, Attie M, Whybrow PC (1997) Bone mineral density and L-thyroxine treatment in rapidly cycling bipolar disorder. Biol Psychiatry 41: 503–506

    Article  PubMed  CAS  Google Scholar 

  • Hayes SG (1989) Long-term use of valproate in primary psychiatric disorders. J Clin Psychiatry 50 (3 Suppl): 35–39

    PubMed  Google Scholar 

  • Hurowitz GI, Liebowitz MR (1993) Antidepressant-induced rapid cycling: six case reports. J Clin Psychopharmacol 13: 52–56

    Article  PubMed  CAS  Google Scholar 

  • Kane JM (1988) The role of neuroleptics in manic-depressive illness. J Clin Psychiatry 49: 12–13

    PubMed  Google Scholar 

  • Keck PE Jr, McElroy SL, Vuckovic A, Friedman LM (1992) Combined valproate and carbamazepine treatment of bipolar disorder. J Neuropsychiatry 4: 319–322

    Google Scholar 

  • Ketter TA, Pazzaglia PJ, Post RM (1992) Synergy of carbamazepine and valproic acid in affective illness: case report and review of the literature. J Clin Psychopharmacol 12: 276–281

    Article  PubMed  CAS  Google Scholar 

  • Kim HR, Delva NJ, Lawson JS (1990) Prophylactic medication for unipolar depressive illness: the place of lithium carbonate in combination with antidepressant medication. Can J Psychiatry 35: 107–114

    PubMed  CAS  Google Scholar 

  • Kishimoto A (1992) The treatment _of affective disorder with carbamazepine: prophylactic synergism of lithium and carbamazepine combination. Prog Neuropsychopharmacol Biol Psychiatry 16: 483–493

    Article  PubMed  CAS  Google Scholar 

  • Kruger S, Braunig P, Young IT (1996) Biological treatment of rapid-cycling bipolar disorder. Pharmacopsychiatry 29: 167–175

    Article  PubMed  CAS  Google Scholar 

  • Kukopulos A, Reginalid D, Laddomada P, Floris G, Serra G, Tondo L (1980) Course of the manic-depressive cycle and changes caused by treatments. Pharmakopsychiatrie-Neuropsychopharmacol 13: 156–167

    CAS  Google Scholar 

  • Kwamie Y, Persad E, Stancer H (1984) The use of carbamazepine as an adjunctive medication in the treatment of affective disorders: a clinical report. Can J Psychiatry 29: 605–608

    PubMed  CAS  Google Scholar 

  • Leibow D (1983) L-thyroxine for rapid-cycling bipolar illness. Am J Psychiatry 140:1255 Lipinski JF Jr, Pope HG Jr (1982) Possible synergistic action between carbamazepine and lithium carbonate: a report of three cases. Am J Psychiatry 139: 948–949

    Google Scholar 

  • McElroy SL, Dessain EC, Pope HG Jr, Cole JO, Keck PE, Frankenberg FR, Aizley HG, O’Brien S (1991) Clozapaine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 52: 411–414

    PubMed  CAS  Google Scholar 

  • Meijer JWA, Binnie CD, Debets RMC, vanParys JAP, DeBeer-Pawlikowski NKB (1984) Possible hazard of valpromide-carbamazepine combination therapy in epilepsy. Lancet 2: 802

    Article  Google Scholar 

  • Mukherjee S, Rosen AM, Caracci G, Shukla S (1986) Persistent tardive dyskinesia in bipolar patients. Arch Gen Psychiatry 43: 342–346

    PubMed  CAS  Google Scholar 

  • Nolen WA (1983) Carbamazepine, a possible adjunct or alternative to lithium in bipolar disorder. Acta Psychiatr Scand 67: 218–225

    Article  PubMed  CAS  Google Scholar 

  • Pazzaglia PJ, Post RM, Ketter TA, George MS, Marangell LB (1993) Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation. Psychiatry Res 49: 257–272

    Article  PubMed  CAS  Google Scholar 

  • Peet M (1994) Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 164: 549–550

    Article  PubMed  CAS  Google Scholar 

  • Peselow ED, Fieve RR, Difiglia C, Sanfilipo MP (1994) Lithium prophylaxis of bipolar illness. The value of combination treatment. Br J Psychiatry 164: 208–214

    Article  PubMed  CAS  Google Scholar 

  • Post RM, Leverich GS, Rosoff AS, Altshuler LL (1990) Carbamazepine prophylaxis in refractory affective disorders: a focus on long-term follow-up. J Clin Psychopharmacol 10: 318–327

    Article  PubMed  CAS  Google Scholar 

  • Post RM, Weiss SRB, Chuang DM (1992) Mechanisms of action of anticonvulsants in affective disorders: comparisons with lithium. J Clin Psychopharmacol 12: 23–35

    Google Scholar 

  • Post RM, Denicoff KD, Leverich GS, Frye MA. Drug-induced switching in bipolar disorder: prevention and management. CNS Drugs, in Druck

    Google Scholar 

  • Prien RF, Klett CF, Caffey EM (1973) Lithium carbonate and imipramine in prevention of affective episodes. Arch Gen Psychiatry 29: 420–425

    PubMed  CAS  Google Scholar 

  • Prien RF, Kupfer DJ, Mansky PA, Small JG, Tuason VB, Voss CB, Johnson WE (1984) Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders: report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium-imipramine combination. Arch Gen Psychiatry 41: 1096–1104

    PubMed  CAS  Google Scholar 

  • Privitera MR, Lamberti JS, Maharaj K (1993) Clozapine in a bipolar depressed patient. Am J Psychiatry 150: 986

    PubMed  CAS  Google Scholar 

  • Quitkin FM, Kane J, Rifkin A, Ramos-Lorenzi JR, Nayak V (1981) Prophylactic lithium carbonate with and without imipramine for bipolar I patients. Arch Gen Psychiatry 38: 902–907

    PubMed  CAS  Google Scholar 

  • Sachs GS (1996) Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. J Clin Psychopharmacol 16 (Suppl 1): 32–47

    Article  Google Scholar 

  • Sachs GS, Weilburg JB, Rosenbaum JF (1990) Clonazepam vs neuroleptics as adjuncts to lithium maintenance. Psychopharmacol Bull 26: 137–143

    PubMed  CAS  Google Scholar 

  • Sharma V, Persad E, Mazmanian D, Karunaratne K (1993) Treatment of rapid cycling bipolar disorder with combination therapy of valproate and lithium. Can J Psychiatry 38: 137–139

    PubMed  CAS  Google Scholar 

  • Sharma V, Persad E (1994) Pharmacotherapy of rapid cycling bipolar disorder: a review. Lithium 5: 117–125

    Google Scholar 

  • Shukla S, Cook BL, Miller MG (1985) Lithium-carbamazepine versus lithium-neuroleptic prophylaxis in bipolar illness. J Aff Disord 9: 219–222

    Article  CAS  Google Scholar 

  • Simhandl Ch, Denk E, Thau K (1993) The comparative efficacy of carbamazepine low and high serum level and lithium carbonate in the prophylaxis of affective disorders. J Aff Disord 28: 221–231

    Article  CAS  Google Scholar 

  • Sovner R (1988) A clinically significant interaction between carbamazepine and valproic acid (letter). J Clin Psychopharmacol 8: 448–449

    Article  PubMed  CAS  Google Scholar 

  • Sporn J, Sachs G (1997) The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. American Psychiatric Association New Research Program and Abstracts 1997: 102

    Google Scholar 

  • Stancer H, Persad E (1982) Treatment of intractable rapid cycling manic-depressive disorder with levo-thyroxine. Arch Gen Psychiatry 39: 311–312

    PubMed  CAS  Google Scholar 

  • Stromgren LS (1990) The combination of lithium and carbamazepine in treatment and prevention of manic-depressive disorder: a review and a case report. Compr Psychiatry 31: 261–265

    Article  PubMed  CAS  Google Scholar 

  • Stuppaeck C, Barnas C, Miller C, Schwitzer J, Fleischhacker W (1990) Carbamazepine in the prophylaxis of mood disorders. J Clin Psychopharmacol 10: 39–42

    Article  PubMed  CAS  Google Scholar 

  • Suppes T, McElroy SL, Gilbert J, Dessain EC, Cole JO (1992) Clozapine treatment of dysphoric mania. Biol Psychiatry 32: 270–280

    Article  PubMed  CAS  Google Scholar 

  • Suppes T, Phillips KA, Judd CR (1994) Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: a report of three cases. Biol Psychiatry 36: 338–340

    Article  PubMed  CAS  Google Scholar 

  • Tohen M, Castillo J, Pope HG, Herbstein J (1994) Concomitant use of valproate and car-bamazepine in bipolar and schizoaffective disorders. J Clin Psychopharmacol 14: 67–70

    Article  PubMed  CAS  Google Scholar 

  • Vanelle JM, Loo H, Galinowski A, de Carvalho W, Bourdel MC, Brochier P, Bouvet O, Brochier T, Olie JP (1994) Maintenance ECT in intractable manic-depressive disorders. Convulsive Therapy 10 (3): 195–205

    PubMed  CAS  Google Scholar 

  • Vestergaard P (1994) Compliance bei Langzeitmedikation mit Lithium: Ein Hauptfaktor erfolgreicher Prophylaxe bei manisch-depressiver Erkrankung. In: Müller-Oerlinghausen B, Berghöfer A (Hrsg.) Ziele and Ergebnisse der medikamentosen Prophylaxe affektiver Psychosen. Thieme, Stuttgart New York, S. 61–64

    Google Scholar 

  • Walden J, Hesslinger B, Calker D van, Berger M (1996) Addition of lamotrigine to val-proate may enhance efficacy in the treatment of bipolar affective disorder. Pharmacopsychiatry 29: 193–195

    Article  PubMed  CAS  Google Scholar 

  • Wehr TA, Goodwin FK (1979) Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 36: 555–559

    PubMed  CAS  Google Scholar 

  • Wehr T, Sack D, Rosenthal N, Cowdry RW (1988) Rapid cycling affective disorder: con-tributing factors and treatment responses in 51 patients. Am J Psychiatry 145: 179–184

    PubMed  CAS  Google Scholar 

  • Whybrow P (1994) The therapeutic use of triiodothyronine and high dose thyroxine in psychiatric disorder. Acta med Austriaca 21: 44–47

    Google Scholar 

Download references

Authors
  1. M. Bauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychiatrische Klinik und Poliklinik, Freie Universität Berlin, Eschenallee 3, D-14050, Berlin, Germany

    Bruno Müller-Oerlinghausen  & Anne Berghöfer (Ärztin) &  (Ärztin)

  2. Psychiatrische Klinik, Ludwig-Maximilian-Universität München, Nußbaumstraße 7, D-80336, München, Germany

    Waldemar Greil

  3. Psychiatrische Klinik, Sanatorium Kilchberg, Alte Landstraße 70–84, CH-8802, Kilchberg Zürich, Switzerland

    Waldemar Greil

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Bauer, M. (1997). Pharmakotherapie bei prophylaxeresistenten affektiven Störungen. In: Müller-Oerlinghausen, B., Berghöfer, A., Greil, W. (eds) Die Lithiumtherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60819-3_41

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60819-3_41

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64570-9

  • Online ISBN: 978-3-642-60819-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation